Generalised Anxiety Disorder Clinical Trial
Official title:
A Neuro-Technological Intervention for Adolescents With Generalised Anxiety Disorder (GAD): A Feasibility Trial
This study aims to evaluate the safety and acceptability of a basic neuro-technological intervention in the treatment of adolescents with Generalised Anxiety Disorder (GAD). Our technology will deliver a mindfulness-based anxiety regulation intervention through a neuro- / bio-feedback-based virtual reality (VR) game interface that is driven by a novel algorithm.
This study is a single-arm open-label test of feasibility. The recruitment target is 30. Outpatient adolescents diagnosed with GAD will be recruited to undergo 8 x 30 minutes intervention sessions over 4 weeks. Participants who are enrolled will continue to receive treatment-as-usual prescribed by their treating psychiatrist, except for the use of psychotropics. This population is selected as they could elucidate whether our intervention can be beneficial as an early intervention program for GAD. During the 8 bi-weekly intervention sessions, participants will don a head-mounted VR display set and a mobile EEG-biosensor. The hardwares are non-invasive. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05278455 -
Self-help Lifestyle Medicine for Generalized Anxiety Symptoms
|
N/A | |
| Completed |
NCT03131505 -
INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1
|
||
| Recruiting |
NCT05549102 -
CBT and the Neural Circuits of Anxiety
|
||
| Terminated |
NCT02347033 -
Trial of Sertraline Versus Cognitive Behaviour Therapy for Generalised Anxiety
|
Phase 4 |